Quicker, low-cost tuberculosis test to enter trials:
This article was originally published in Clinica
Executive Summary
A US company has said it is ready to enter clinical trials of a simple, low-cost test for Mycobacteria tuberculosis, the organism responsible for tuberculosis. Infectech, the Sharon, Pennsylvania-based company which developed the test said the market for the test could reach $700 million a year.